Corcept Therapeutics Inc (CORT)
24.17
-0.91
(-3.63%)
USD |
NASDAQ |
May 03, 14:53
Corcept Therapeutics Gross Profit (TTM): 475.89M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 475.89M |
September 30, 2023 | 443.94M |
June 30, 2023 | 422.37M |
March 31, 2023 | 408.30M |
December 31, 2022 | 396.47M |
September 30, 2022 | 392.36M |
June 30, 2022 | 386.83M |
March 31, 2022 | 374.97M |
December 31, 2021 | 360.70M |
September 30, 2021 | 347.71M |
June 30, 2021 | 337.96M |
March 31, 2021 | 335.09M |
December 31, 2020 | 348.29M |
September 30, 2020 | 350.27M |
June 30, 2020 | 345.21M |
March 31, 2020 | 328.76M |
December 31, 2019 | 300.98M |
September 30, 2019 | 279.78M |
June 30, 2019 | 262.86M |
March 31, 2019 | 253.14M |
December 31, 2018 | 246.03M |
September 30, 2018 | 232.90M |
June 30, 2018 | 211.55M |
March 31, 2018 | 185.18M |
December 31, 2017 | 155.65M |
Date | Value |
---|---|
September 30, 2017 | 126.78M |
June 30, 2017 | 106.04M |
March 31, 2017 | 90.56M |
December 31, 2016 | 79.26M |
September 30, 2016 | 70.62M |
June 30, 2016 | 62.56M |
March 31, 2016 | 54.78M |
December 31, 2015 | 48.92M |
September 30, 2015 | 43.08M |
June 30, 2015 | 37.12M |
March 31, 2015 | 31.24M |
December 31, 2014 | 25.67M |
September 30, 2014 | 20.97M |
June 30, 2014 | 16.52M |
March 31, 2014 | 12.75M |
December 31, 2013 | 10.21M |
September 30, 2013 | 7.517M |
June 30, 2013 | 5.954M |
March 31, 2013 | 4.913M |
December 31, 2012 | 3.216M |
September 30, 2012 | 1.858M |
June 30, 2012 | 0.827M |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
262.86M
Minimum
Jun 2019
475.89M
Maximum
Dec 2023
363.09M
Average
350.27M
Median
Sep 2020
Gross Profit (TTM) Benchmarks
Ultragenyx Pharmaceutical Inc | 389.04M |
Alnylam Pharmaceuticals Inc | 1.518B |
Catalyst Pharmaceuticals Inc | 346.24M |
United Therapeutics Corp | 2.220B |
XOMA Corp | -- |